United States · FDA National Drug Code directory

Guaifenesin and Pseudoephedrine HCL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 55111-799_9e158de3-9d7a-e6f8-2e19-5ef46d33e8cd
Product NDC: 55111-799
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Guaifenesin and Pseudoephedrine HCL
Labeler: Dr. Reddys Laboratories Limited
Marketing category: ANDA
Marketing start / end (source format): 20171229
Source listing expiry: 20261231

Source-listed ingredients

GUAIFENESIN — 1200 mg/1
PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (55111-799-04) / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (55111-799-06) · 55111-799-04
1 BLISTER PACK in 1 CARTON (55111-799-12) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-799-12
2 BLISTER PACK in 1 CARTON (55111-799-24) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-799-24
3 BLISTER PACK in 1 CARTON (55111-799-36) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-799-36

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →